← FDA Drug Approvals (Drugs@FDA)
FLUDEOXYGLUCOSE F18
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: 3D IMAGING DRUG · Approved 2015-10-30
Drug application
- FDA Application #
ANDA203778- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- FLUDEOXYGLUCOSE F18
- Generic name
- FLUDEOXYGLUCOSE F18
- Active ingredients
- FLUDEOXYGLUCOSE F-18
- Dosage form
- INJECTABLE
- Route
- INTRAVENOUS
- Marketing status
- Prescription
- Sponsor
- 3D IMAGING DRUG
- Manufacturer
- 3D Imaging Drug Design and Development LLC
- First approval
- 2015-10-30
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown